Devi, P., Sridevi, J., Kakan, S., Saxena, S., Jeankumar, V., , … Sriram, D. (2015). Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis. Tuberculosis (Edinburgh, Scotland), 95(6), 786-794. https://doi.org/10.1016/j.tube.2015.04.010

Jeankumar, V., Saxena, S., Vats, R., Reshma, R., Janupally, R., Kulkarni, P., … Sriram, D. (2016). Structure-Guided Discovery of Antitubercular Agents That Target the Gyrase ATPase Domain. ChemMedChem, 11(5), 539-48. https://doi.org/10.1002/cmdc.201500556 (Original work published 2016)

Samala, G., Devi, P., Saxena, S., Meda, N., Yogeeswari, P., & Sriram, D. (2016). Design, synthesis and biological evaluation of imidazo 2,1-b thiazole and benzo d imidazo 2,1-b thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors. Bioorganic & Medicinal Chemistry, 24(6), 1298-307. https://doi.org/10.1016/j.bmc.2016.01.059 (Original work published 2016)

Jeankumar, V., Reshma, R., Vats, R., Janupally, R., Saxena, S., Yogeeswari, P., & Sriram, D. (2016). Engineering another class of anti-tubercular lead: Hit to lead optimization of an intriguing class of gyrase ATPase inhibitors. European Journal of Medicinal Chemistry, 122, 216-231. https://doi.org/10.1016/j.ejmech.2016.06.042 (Original work published 2016)

Reshma, R., Saxena, S., Bobesh, K., Jeankumar, V., Gunda, S., Yogeeswari, P., & Sriram, D. (2016). Design and development of new class of Mycobacterium tuberculosisl-alanine dehydrogenase inhibitors. Bioorganic & Medicinal Chemistry, 24(18), 4499-4508. https://doi.org/10.1016/j.bmc.2016.07.051 (Original work published 2016)